Excipients & Specialty Ingredients
Analytical & Bioanalytical Services
Company Overview
About
Matexcel is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:United States
Founded:1993
Employees:1,977
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Global
Regulatory Approvals
Drug Approval N2E341
FDA · #APR-W587M10A · 2021-12-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-IJOREEMN
Issued: 2020-11-26
Expires: 2025-02-01
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-LZQE3QI4
Issued: 2020-03-03
Expires: 2025-05-28
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-XOHAA4XE
Issued: 2020-01-13
Expires: 2025-02-02
Loading CDMO intelligence...
Key facts about Matexcel
- Matexcel is headquartered in the United States.
- Matexcel was founded in 1993.
- Matexcel has 1,977 employees.
- Matexcel's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Matexcel
Directory pages this company appears in, each with the full list of matching manufacturers.